Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

January 31, 2024

https://www.globenewswire.com/news-release/2024/01/31/2820997/0/en/Passage-Bio-to-Present-at-Guggenheim-Healthcare-Talks-6th-Annual-Biotechnology-Conference.html

PHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024 at 10:00 a.m. ET.

Read more at globenewswire.com

Related news for (PASG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.